2025 annual financial data
Axsome Therapeutics 2025 Operating margin
Direct answer
Operating margin was -26.51%.
Operating income was -169,235,000 USD and net income was -183,174,000 USD.
Operating cash flow was -93,405,000 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 638,496,000 USD
- Operating income
- -169,235,000 USD
- Net income
- -183,174,000 USD
- Operating cash flow
- -93,405,000 USD